Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6851
BNY Mellon Concentrated International ETF
BKCI
$134M
| $875K | ﹤0.01% |
+17,818
| New | +$816K |
|
|
SCPH
6852
DELISTED
scPharmaceuticals
SCPH
| $875K | ﹤0.01% |
139,496
+134,506
| +2,696% | +$770K |
|
6853
CALL
Genesis Energy
GEL
$1.93B
| $874K | ﹤0.01% |
75,500
+42,900
| +132% | +$491K |
|
6854
CALL
Upbound Group
UPBD
$1.14B
| $873K | ﹤0.01% |
25,700
+23,600
| +1,124% | +$703K |
|
|
LQIG
6855
DELISTED
State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF
LQIG
| $872K | ﹤0.01% |
8,963
-8,978
| -50% | -$828K |
|
6856
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
| $872K | ﹤0.01% |
19,755
+10,866
| +122% | +$442K |
|
6857
Inspire Medical Systems
INSP
$1.65B
| $872K | ﹤0.01% |
4,285
-44,767
| -91% | -$7.25M |
|
|
VIRX
6858
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $872K | ﹤0.01% |
1,529,072
+8,668
| +0.6% | +$5.32K |
|
6859
National Healthcare
NHC
$3.5B
| $872K | ﹤0.01% |
9,430
-9,324
| -50% | -$715K |
|
6860
Tarsus Pharmaceuticals
TARS
$3.04B
| $871K | ﹤0.01% |
43,037
+37,173
| +634% | +$621K |
|
6861
PUT
United States Brent Oil Fund
BNO
$785M
| $871K | ﹤0.01% |
31,900
+200
| +0.6% | +$5.84K |
|
6862
VTEX
VTEX
$618M
| $871K | ﹤0.01% |
126,565
-466,733
| -79% | -$2.85M |
|
6863
PUT
Phinia Inc
PHIN
$2.73B
| $870K | ﹤0.01% |
28,720
-11,980
| -29% | -$321K |
|
6864
PUT
Fortune Brands Innovations
FBIN
$5.71B
| $868K | ﹤0.01% |
11,400
+1,700
| +18% | +$112K |
|
6865
Tiptree Inc
TIPT
$672M
| $868K | ﹤0.01% |
45,780
+28,386
| +163% | +$491K |
|
6866
2x Bitcoin ETF
BITX
$849M
| $868K | ﹤0.01% |
38,135
-383
| -1% | -$7.02K |
|
6867
PUT
Invesco CurrencyShares Swiss Franc Trust
FXF
$395M
| $867K | ﹤0.01% |
8,200
+2,800
| +52% | +$281K |
|
6868
CALL
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $867K | ﹤0.01% |
19,200
-54,000
| -74% | -$2.31M |
|
6869
Expro Ltd
XPRO
$2.1B
| $866K | ﹤0.01% |
54,400
-251,254
| -82% | -$4.34M |
|
6870
Fidelity Stocks for Inflation ETF
FCPI
$285M
| $865K | ﹤0.01% |
+24,725
| New | +$819K |
|
6871
Sumitomo Mitsui Financial
SMFG
$167B
| $864K | ﹤0.01% |
89,307
-150,852
| -63% | -$1.46M |
|
6872
CALL
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $864K | ﹤0.01% |
12,000
+8,500
| +243% | +$577K |
|
6873
CALL
Primerica
PRI
$9.65B
| $864K | ﹤0.01% |
4,200
-3,100
| -42% | -$634K |
|
6874
PUT
Revvity
RVTY
$13B
| $864K | ﹤0.01% |
7,900
+800
| +11% | +$77.2K |
|
6875
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $863K | ﹤0.01% |
9,056
-82,278
| -90% | -$7.07M |
|
Similar funds
Citadel Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Citadel Advisors opened 1,585 new positions and closed 1,624 in Q4 2023.
- Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.